Stay updated on Mazindol CR in Adults with ADHD Clinical Trial
Sign up to get notified when there's something new on the Mazindol CR in Adults with ADHD Clinical Trial page.

Latest updates to the Mazindol CR in Adults with ADHD Clinical Trial page
- Check4 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA notice was added above the page announcing NIH website transition updates and stating that federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check18 days agoChange DetectedThe footer site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedAn error page displaying 403 Forbidden is now shown when loading the study record. The page includes a minimal HTML structure, a 403 title, and a Home link, replacing the expected study details.SummaryDifference17%

- Check67 days agoChange DetectedFooter revision indicator updated from v3.6.5 to v3.6.6, signaling a minor platform update. The change does not alter the study information or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Mazindol CR in Adults with ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mazindol CR in Adults with ADHD Clinical Trial page.